Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Moxidectin, Praziquantel
Zoetis UK Limited
QP54AB52
Moxidectin, Praziquantel
Oral gel
POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person
Horses
Endectocide
Expired
2012-07-18
Revised: June 2014 AN: 01740/2013 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Pramoxiquest Oral Gel for Horses and Ponies 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 g contains: ACTIVE SUBSTANCE: Moxidectin 19.5 mg Praziquantel 121.7 mg EXCIPIENTS: Benzyl alcohol 220.0 mg Butylhydroxytoluene 0.8 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral gel Pale yellow to orange/pink gel 4. CLINICAL PARTICULARS 4.1. TARGET SPECIES Horses and ponies. 4.2. INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES Indicated for the treatment of mixed cestodes and nematodes or arthropods infections, caused by moxidectin and praziquantel sensitive strains of: Large strongyles: _Strongylus vulgaris_ (adult stages) _Strongylus edentatus_ (adult stages) _Triodontophorus brevicauda_ (adults) _Triodontophorus serratus_ (adults) _Triodontophorus tenuicollis _ (adults) Small strongyles (adults and intraluminal larval stages): _Cyathostomum _spp. _Cylicocyclus _spp_._ _Cylicostephanus _spp_._ _Cylicodontophorus_ spp. _Gyalocephalus _spp. Ascarids: Revised: June 2014 AN: 01740/2013 Page 2 of 6 _Parascaris equorum_ (adult) Other species: _Oxyuris equi _(adult stages) _Habronema muscae _(adults) _Gasterophilus intestinalis _(L2, L3) _Gasterophilus nasalis _(L2, L3) _Strongyloides westeri _(adults) _Trichostrongylus axei_ (adults) Tapeworm (adults): _Anoplocephala perfoliata_ _Anoplocephala magna_ _Paranoplocephala mammillana_ The egg reappearance period of small strongyles is 90 days. The veterinary medicinal product is effective against (developing) intramucosal L4 stages of small strongyles. At 8 weeks after treatment, early (hypobiotic) EL3 stages of small strongyles are eliminated. 4.3. CONTRAINDICATIONS Do not administer to young foals less than 6.5 months. Do not administer in cases of known hypersensitivity to the active ingredients or to any of the excipients. The product has b Read the complete document